Cailin Conner

Urban Health Today

The relationship between obesity and cancer has been widely studied, but the impact of metabolic health on the outcomes of chronic myeloid leukemia (CML) in obese individuals is not well understood. &ldquo;Association of Obesity Under Different Metabolic Status With Adverse Outcomes in Patients With Chronic Myeloid Leukemia: A Retrospective Cohort Study,&rdquo; recently published in the Journal of Diabetes, aimed to fill this gap by examining the association between abnormal metabolic obesity states and the outcomes of CML.The study utilized data from the Nationwide Readmissions Database and included 7931 adult patients with CML discharged between January 1, 2018, and June 30, 2018. The study population was divided into 4 groups based on body mass index and metabolic status. The primary outcome was adverse outcomes of CML, including nonremission (NR)/relapse and severe mortality risk. The data were analyzed using multivariate logistic regression analysis.The study found that &ldquo;metabolically unhealthy normal weight and metabolically unhealthy obesity were all risk factors for adverse outcomes of CML compared with metabolically healthy normal weight.&rdquo;The results showed no significant difference in the metabolically healthy obese group. Researchers found that metabolically unhealthy normal weight and metabolically unhealthy obesity were both associated with increased risk of NR or relapse in female patients by 1.23-fold and 1.40-fold, respectively. However, male patients did not show such a risk. Furthermore, patients with a higher number of metabolic risk factors or those with dyslipidemia were more likely to experience adverse outcomes regardless of their obesity status.These findings highlight the importance of considering metabolic health in the management of CML. The study suggests that metabolic abnormalities, rather than obesity alone, are associated with adverse outcomes in patients with CML.&ldquo;Future treatment of patients with CML should consider the effects of obesity on their adverse outcomes under different metabolic status, especially in female patients,&rdquo; the researchers concluded.Source: <a href="https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13383" target="_blank" rel="noopener">Journal of Diabetes</a>

Payton White, BS

How Sleep Quality Influences Risk of Alzheimer’s Disease

Alzheimer's & Dementia

Lou Portero

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Latest News

Metabolic Health Affects CML Outcomes in Obese Individuals

Blood Cancers

Metabolically unhealthy normal weight and metabolically unhealthy obesity were associated with increased risk of adverse outcomes in CML, particularly in female patients.

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe